scispace - formally typeset
W

Wilhelm G. Lachnit

Researcher at Hoffmann-La Roche

Publications -  5
Citations -  1180

Wilhelm G. Lachnit is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Schild regression & Patch clamp. The author has an hindex of 5, co-authored 5 publications receiving 1135 citations.

Papers
More filters
Journal ArticleDOI

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice.

TL;DR: P2X3 is critical for peripheral pain responses and afferent pathways controlling urinary bladder volume reflexes and may have therapeutic potential in the treatment of disorders of urine storage and voiding such as overactive bladder.
Journal ArticleDOI

Subunit specificity of polyclonal antisera to the carboxy terminal regions of P2X receptors, P2X1 through P2X7

TL;DR: Polyclonal antisera generated to peptides corresponding to the carboxy termini of the seven cloned rat P2X receptors were compared using membranes from CHO‐K1 or 1321N1 cells expressing recombinant rat or human P2 X receptors to find useful reagents for the analysis of the P2x receptor subtypes in native tissues as well as for measuring receptor expression levels in transfected cell lines.
Journal ArticleDOI

Pharmacological characterization of an α1A‐adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat

TL;DR: In this paper, the alpha 1-adrenoceptor population mediating contraction of caudal artery of rat has been characterized by using quantitative receptor pharmacology, and a selective alpha 1 A-adrienoceptor antagonist, A-61603, produced non-parallel, biphasic, dextral shifts of E/[A] curves to NA yielding a pKb of 8.9 (Schild regression slope = 1.0).
Journal ArticleDOI

Regulated expression of the rat recombinant P2X3 receptor in stably transfected CHO-K1 tTA cells

TL;DR: These results show for the first time, expression of a functional, homomeric recombinant rat P2X(3) receptor which is under regulated expression in a stably transfected mammalian cell line.
Journal ArticleDOI

SDZ NVI 085, an α1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties

TL;DR: In this article, (±)-SDZ NVI 085 (3,4,4 a 5,10,10 a -hexahydro-6-methoxy-4-methyl-9-methylthio-2 H -naphth[2,3, b ]-1,4-oxazine hydrochloride), an α 1 -adrenoceptor agonist, produced a concentration-dependent relaxation (pIC 50 of 72 ± 01) in the isolated caudal artery of rat precontracted with serotonin (5-